Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphologi...
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Neoadjuvant endocrine therapy (NET) has shown efficacy in terms of clinical response and surgical outcome in postmenopausal patients with estrogen receptor-positive / HER2-negative breast cancer (ER+/HER2- BC) but monitoring of tumor response is challenging. The aim of the present study was to investigate the value of an early metabolic response co...
Alternative Titles
Full title
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0804565e7e7745578f6e0277ab0ef85d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0804565e7e7745578f6e0277ab0ef85d
Other Identifiers
ISSN
1470-7330,1740-5025
E-ISSN
1470-7330
DOI
10.1186/s40644-020-0287-4
